Share
Market Research Report

INTRAMUSCULAR VACCINE ADJUVANTS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Segmentation
  • By Type of AdjuvantsOil-based Adjuvants · Liposome-based Adjuvants · Polymer-based Adjuvants · Mineral-based Adjuvants · Others
  • By End-usersPediatrics · Adults · Geriatrics
  • By ApplicationsInfectious Diseases · Cancer · Others
  • By Distribution ChannelsHospitals · Clinics · Research Centers)By Region (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific
  • Published In16 Mar 2026
  • Report CodeCMI5650
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026-2033
  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Intramuscular Vaccine Adjuvants, By Type of Adjuvants
      • Market Intramuscular Vaccine Adjuvants, By  End users
      • Market Intramuscular Vaccine Adjuvants, By Applications
      • Market Intramuscular Vaccine Adjuvants, By Distribution Channels
      • Market Intramuscular Vaccine Adjuvants, By Region
    • Coherent Opportunity Map (COM)
  3. Global Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
      • Drivers
        • Growing geriatric population coupled with increasing prevalence of chronic diseases
        • Increased government vaccination recommendations
      • Restraints
        • Side-effects and toxicity of adjuvants
      • Opportunities
        • Increased research and development activities in this field
    • Impact Analysis
    • Key Highlights
    • Regulatory Scenario
    • Product launch/Approvals
    • PEST Analysis
    • PORTER’s Analysis
    • Merger and Acquisition Scenario
  4.  Global Intramuscular Vaccine Adjuvants Market, By Type of Adjuvants, 2021 - 2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2026 – 2033
      • Segment Trends
    • Oil-based Adjuvants
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
    • Liposome-based Adjuvants
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
    • Liposome-based Adjuvants
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
    • Mineral-based Adjuvants
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
  5. Global Intramuscular Vaccine Adjuvants Market, By End Users, 2021 - 2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2026 – 2033
      • Segment Trends
    • Pediatrics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
    • Adults
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
    • Geriatrics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
  6. Global Intramuscular Vaccine Adjuvants Market, By Applications, 2021 - 2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2026 – 2033
      • Segment Trends
    • Infectious diseases
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
    • Cancer
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
  7. Global Intramuscular Vaccine Adjuvants Market, By Distribution Channels, 2021 - 2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2026 – 2033
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
    • Clinics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
    • Research Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
  8. Global Intramuscular Vaccine Adjuvants Market, By Region, 2021 - 2033, (USD Mn)

    • Introduction
      • Market Share Analysis, By Country, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, For Country 2026 –2033
      • Country Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
        • U.S.
        • Canada
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Type of Adjuvants, 2021 - 2033, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By End Users, 2021 - 2033, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Applications, 2021 - 2033, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channels, 2021 - 2033, (USD Mn)
        • Germany
        • U.K.
        • Spain
        • France
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Type of Adjuvants, 2021 - 2033, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By End Users, 2021 - 2033, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Applications, 2021 - 2033, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channels, 2021 - 2033, (USD Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Type of Adjuvants, 2021 - 2033, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By End Users, 2021 - 2033, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Applications, 2021 - 2033, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channels, 2021 - 2033, (USD Mn)
        • Brazil
        • Argentina
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Type of Adjuvants, 2021 - 2033, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By End Users, 2021 - 2033, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Applications, 2021 - 2033, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channels, 2021 - 2033, (USD Mn)
        • GCC Countries
        • Israel
        • Rest of Middle East
        • South Africa
        • North Africa
        • Central Africa
  9. Competitive Landscape

    • Novavax, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Adjuvance Technologies, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Invivogen
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Vaxine Pty Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • SEPPIC
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • SPI Pharma, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Agenus Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Avanti Polar Lipids, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • CSL Limited
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • OZ Biosciences
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
      • Analyst Views
  10. Section

    • Research Methodology
    • About us